Concinnity

Curated by Signal

Provider of AI-driven platform for developing gene and cell therapies

Overview

Provider of AI-driven platform for developing gene and cell therapies. It has RNA-based control systems whichwill form part of the gene therapy cassette and enable precise control of therapeutic activity in response to patient disease state, recognise tissue type, or by clinical control of the therapy after administration.

Key facts

Founded: 2021
Headquarters: Edinburgh, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Jung Type Indicator
Provider of online psychometric assessment tests for employees and individuals
Health TechnologyBedford, United Kingdom
Fertilitae
App based platform to assist individuals and couples in preparing for pregnancy
Health TechnologyLondon, United Kingdom
Zapped
Provider of an online doctor consultation platform with dermatologists
Health TechnologyLondon, United Kingdom

About Concinnity

What does Concinnity do?

Provider of AI-driven platform for developing gene and cell therapies.

Where is Concinnity headquartered?

Concinnity is headquartered in Edinburgh, United Kingdom.

When was Concinnity founded?

Concinnity was founded in 2021.

Which sector is Concinnity in?

Concinnity operates in Health Technology.

Who are Concinnity's competitors?

Companies similar to Concinnity include Jung Type Indicator, Fertilitae, and Zapped.